#rewriterna - Twitter Hashtag

about 3 years ago

🏌️⛳️ It was a par-ty last week for #TeamAscidian’s summer outing at the new @Puttshack in #Boston! This approach to mini-golf pairs traditional methods with modern technology – a concept we're all too familiar with as we #RewriteRNA via #ExonEditing!

AscidianTx's tweet photo. 🏌️⛳️ It was a par-ty last week for #TeamAscidian’s summer outing at the new @Puttshack in #Boston!

This approach to mini-golf pairs traditional methods with modern technology – a concept we're all too familiar with as we #RewriteRNA via #ExonEditing! https://t.co/bi8GSsgMwq

0

2

0

137

Ascidian Therapeutics @AscidianTx

over 3 years ago

Every patient has a unique story, and hearing them inspires our team and work to #RewriteRNA to address genetically defined diseases like Stargardt. Read Gavin’s story as shared with @FightBlindness 👉 https://t.co/CeMVNKeIwe #HealthyVisionMonth

Foundation Fighting Blindness

@FightBlindness

over 3 years ago

Meet Gavin, who was diagnosed with #Stargardt disease at the age of 19. In his own words, Gavin shares his experience over the last 13 years adjusting to the unpredictability of his #VisionLoss and how being a new parent has shifted his mindset. https://t.co/uQXI28YnjZ

FightBlindness's tweet photo. Meet Gavin, who was diagnosed with #Stargardt disease at the age of 19. In his own words, Gavin shares his experience over the last 13 years adjusting to the unpredictability of his #VisionLoss and how being a new parent has shifted his mindset. https://t.co/uQXI28YnjZ https://t.co/1GZdVaCKqy

0

9

1

1K

0

3

0

251

Ascidian Therapeutics @AscidianTx

over 3 years ago

Curious about our science? Our CMO, Jay Barth, delivers a concise overview about our work to #RewriteRNA and the latest from our lead program in ABCA4 retinopathies all in one take! Listen to what Jay has to say from the frontlines of #ARVO23 here 👇 @OphthTimes

Ophthalmology Times @OphthTimes

over 3 years ago

We talked with Jay Barth, MD, about the work at Ascidian Therapeutics and their research into developing a new way to administer gene therapy at this year's ARVO meeting. #ARVO2023 Watch the Interview: https://t.co/2r5KjSbUUz

OphthTimes's tweet photo. We talked with Jay Barth, MD, about the work at Ascidian Therapeutics and their research into developing a new way to administer gene therapy at this year's ARVO meeting. #ARVO2023

Watch the Interview: https://t.co/2r5KjSbUUz https://t.co/EsiaBsy2OB

0

3

0

737

0

3

0

126

Ascidian Therapeutics @AscidianTx

over 3 years ago

In support of #RareDiseaseDay, we��re sharing three things to know about #Stargardt disease and our work to #RewriteRNA for people affected by this genetically inherited eye disorder. Thanks to Tayla Cormier for sharing your passion and expertise! 👇

0

4

0

259

Ascidian Therapeutics @AscidianTx

almost 4 years ago

TGIF🎉! Our CEO & Board Chair recently had the pleasure of talking science w/@Cormac_Sheridan. His article covers the potential of our #ExonEditing platform to #RewriteRNA & treat human disease. We invite you to check it out 👉 https://t.co/STRS4skoyJ

0

6

1

0

Ascidian Therapeutics @AscidianTx

almost 4 years ago

Although today marks the last day of #BlindnessAwarenessMonth, our work to #RewriteRNA to address #Stargardt disease, the most common form of inherited macular degeneration, affecting ~30,000 people in the US, has just begun. Learn about Stargardt👇 https://t.co/vHS73vx2Rp

0

3

1

0

Top Tweets for #rewriterna

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users